Skip to main content

We narrowed to 973 results for: nanobody

Showing: 161 - 180 of 973 results
  1. pET-15b-aδNb072

    Plasmid
    #204627
    Purpose
    Expresses the anti-IgD nanobody 072 (aδNb072) in the bacterial periplasm. aδNb072 is an orthosteric inhibitor of human anti-Phl p 7 antibodies of clone 102.1F10.
    Depositor
    Insert
    aδNb072
    Tags
    His6 and TEV protease cleavage site
    Expression
    Bacterial
    Promoter
    T7
    Available Since
    Nov. 29, 2023
    Availability
    Academic Institutions and Nonprofits only
  2. pET24a-LaM4-2xTS

    Plasmid
    #162779
    Purpose
    Bacterial expression of a functionalized anti-mCherry (LaM4) nanobody fused to two tyrosine sulfation (TS) motifs. LaM4-2xTS also contains a T7, HA, BAP and His6 epitope
    Depositor
    Insert
    anti-mCherry nanobody fused to two TS sites, T7, HA, BAP and His6 epitope
    Tags
    BAP, HA, His6, T7, and TS site from proCCK
    Expression
    Bacterial
    Promoter
    T7
    Available Since
    Oct. 3, 2022
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (AAV1)

    Viral Prep
    #75470-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (#75470). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry plasmid DNA. CAG-driven, Flp recombinase-dependent expression of channelrhodopsin H134R mutant fused to mCherry. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    mCherry
    Available Since
    March 2, 2020
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-EF1a-Flp-DOG-NW (AAV1)

    Viral Prep
    #75469-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-Flp-DOG-NW (#75469). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flp-DOG-NW plasmid DNA. EF1a-driven expression of Flp recombinase dependent on GFP (Flp-DOG); to be coinjected with GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF-1a
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only
Showing: 161 - 180 of 973 results